FutureFuel Corp. (FF) presents a deteriorating liquidation recovery posture as of March 31, 2026. The TAG_CONTEXT XBRL tag list is empty for this filing, meaning no balance-sheet line items are available for tag-level analysis. All quantitative observations are drawn from the filing narrative and inline XBRL values embedded in the filing body. The MFFAIS-provided liquidation values show: cash liquidation value of $33.6M, liquid liquidation value of $43.0M, and operating liquidation value of $64.2M. These figures imply that even under the most optimistic operating-asset scenario, recovery to equity is modest relative to the operating losses being generated. The company reported a net loss of $20.6M for Q1 2026, up from $18.1M in Q1 2025 (as adjusted for LIFO-to-weighted-average-cost inventory accounting change retroactively applied). Operating cash outflow was $20.0M in Q1 2026 versus $5.4M in Q1 2025, a significant deterioration driven primarily by a $17.9M cash outflow from accounts receivable growth and derivative settlement losses. The biofuel segment generated a gross loss of $13.3M, largely from $9.1M in realized derivative settlement losses plus $2.5M unrealized losses on futures positions. The chemical segment improved but still reported a $2.5M gross loss. There is no funded debt outstanding on the $35M revolving credit facility. Key liability-side items from the narrative include: accrued liabilities of $3.6M (up from $2.8M at year-end 2025), other noncurrent liabilities of $7.0M (including $2.8M railroad grants, $2.7M employment tax credits, and $1.5M asset retirement obligation — all of which remain at face value in a liquidation). A post-period event of material concern: on May 9, 2026, a localized fire at the Batesville biodiesel facility caused a temporary shutdown of biodiesel production. The extent of asset damage and repair costs are unquantified in the filing, representing an unbooked contingent liability and potential PP&E impairment that would reduce liquidation recovery. The company elected a LIFO-to-weighted-average-cost inventory accounting change in Q1 2026, applied retrospectively; this shifts inventory values but does not affect the 60% recovery haircut applied to inventory in a liquidation scenario. Interest income dropped sharply to $298K in Q1 2026 from $1.2M in Q1 2025, indicating the cash and short-term investment base is materially lower than a year ago. The dividend was cut from $0.06/share to $0.01/share for Q2 2026, signaling capital conservation. No pension obligation is disclosed. Filing discusses derivative instrument fair value liabilities ($2.5M net liability at March 31, 2026 versus $13K at December 31, 2025) in MD&A but the balance-sheet line carrying this exposure is embedded in 'other current assets' net of margin account — the filing does not separately tag the derivative liability as a standalone balance-sheet item in XBRL.
▼ Community Notes